One of the primary sources of ineffectiveness in current cancer treatment is not necessarily our lack of understanding of what treatment regimens work, but rather our limited understanding of what does not work when current understanding suggests that it should. This team will develop effective tools to extract clinical value from existing databases by correlating phenotypic, and where possibly genotypic, traits with the administered treatment drugs and their eventual treatment outcomes. The long term vision of this team is to manage information such that cancer patients can benefit from faster and more accurate diagnosis based on personalized phenotypical traits which generic therapy may fail to address. This team has been active from September 1, 2015 - current.

A presentation of this project is avaliable here.